Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review

William R. Short(University of Pennsylvania), Bryn Jones(ViiV Healthcare (United Kingdom)), Ana M. Puga(Children's Diagnostic & Treatment Center), Vani Vannappagari, Parul Patel(Novartis (United States)), Gustavo Verdier, Annemiek de Ruiter(ViiV Healthcare (Spain))

Infectious Diseases and Therapy

December 9, 2024

10.1007/s40121-024-01085-z

Cited by 5

Related Papers

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

|The Lancet|1996|631

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006

|AIDS|2008|582

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011

|AIDS|2014|397

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy

|AIDS|2002|359

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America

|Clinical Infectious Diseases|2020|246